| Financial Year |
March 31 2023 |
| Monetary Funds |
898,240,753.84 |
| Held-for-trading Financial Assets |
650,795,704.13 |
| Notes Receivable |
6,670,452.00 |
| Accounts Receivable |
252,271,635.43 |
| Advances to Suppliers |
1,110,882,814.64 |
| Other Receivables |
57,841,154.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
10,817,763.99 |
| Dividend Receivable |
-- |
| Inventories |
1,718,114,665.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
169,835,329.54 |
| Total Current Assets |
4,864,652,509.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,914,590.81 |
| Investment Properties |
-- |
| Fixed Assetes |
160,584,701.23 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
296,432,025.06 |
| R&D expenses |
25,237,068.28 |
| Goodwill |
299,825,844.80 |
| Long-Term Deferred and Prepaid Expenses |
102,676,043.08 |
| Deferred Income Tax Assets |
151,402,994.98 |
| Other Non-Current Assets |
1,726,393,107.58 |
| Sub-Total of Non-Current Assets |
3,032,445,316.47 |
| Total Assets |
7,897,097,826.14 |
| Short-Term Loans |
1,001,099,411.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
116,145,336.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,561,965.64 |
| Taxes Payable |
4,699,931.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
67,403,515.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,620,235.29 |
| Other Current Liabilities |
255,196,333.18 |
| Sub-Total of Current Liabilities |
3,446,315,249.28 |
| Long-term Loans |
200,144,444.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,891,290.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
400,248,187.06 |
| Total Liabilities |
3,846,563,436.34 |
| Paid-In Capital(Or Share Stock) |
217,250,112.00 |
| Capital Surplus |
3,165,175,183.52 |
| Surplus Reserve |
74,475,798.45 |
| LESS:Treasury Stock |
63,393,876.00 |
| Undistributed Profits |
571,055,592.84 |
| Minority Stockholder's Interest |
-24,769,251.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,075,303,641.36 |
| Owner's Equity（Stockholder's Equity） |
4,050,534,389.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,897,097,826.14 |
